AAFA's Advocacy for Health Equity Leads to White House Address on Asthma Inhaler Pricing
03 avr. 2024 14h45 HE
|
Asthma and Allergy Foundation of America
Washington, DC, April 03, 2024 (GLOBE NEWSWIRE) -- As the leading advocacy organization focused on improving the access and affordability of asthma inhalers, the Asthma and Allergy Foundation of...
AAFA Statement on EPA Cars Rule
20 mars 2024 13h46 HE
|
Asthma and Allergy Foundation of America
Washington, D.C., March 20, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) applauds a new rule by the Environmental Protection Agency (EPA) that will drive America...
AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
18 mars 2024 13h45 HE
|
Asthma and Allergy Foundation of America
Washington, DC, March 18, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) welcomes efforts to make asthma medicines more affordable and accessible. AAFA continues to...
Chronic Disease Management Market revenue to reach USD 27 Billion by 2035, says Research Nester
13 mars 2024 07h30 HE
|
Research Nester
New York, March 13, 2024 (GLOBE NEWSWIRE) -- The global chronic disease management market size is projected to grow at a CAGR of over ~13% from 2023 to 2035. The market is expected to garner a...
United States Asthma Market Report - Insights into Primary HCP Interaction, Treatment Awareness, Satisfaction, Control and Clinical Trial Interest
12 mars 2024 13h56 HE
|
Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Asthma in America 2023: Key Insights into Treatment Awareness & Satisfaction" report has been added to ResearchAndMarkets.com's offering. More...
AAFA Statement on Asthma Inhaler Price Caps
08 mars 2024 08h53 HE
|
Asthma and Allergy Foundation of America
Washington, DC, March 08, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) is leading advocacy efforts to change the drug pricing ecosystem and to make medicines more...
Soft Mist Inhalers Market Size Projected to Grow at a 6.8% CAGR, Globally, by 2031 - Exclusive Report by Transparency Market Research, Inc.
29 févr. 2024 01h45 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global soft mist inhalers market is projected to grow at a CAGR of 6.8% from 2022 to...
Monaghan Medical Corporation Attains ISO 14001 Certification for Environmental Management Excellence
27 févr. 2024 07h00 HE
|
Monaghan Medical Corporation
Monaghan Medical Corporation is proud to have achieved ISO 14001 certification
Allergy Immunotherapy Market revenue to cross USD 6 Billion by 2036, says Research Nester
01 févr. 2024 07h00 HE
|
Research Nester
New Yorke , Feb. 01, 2024 (GLOBE NEWSWIRE) -- The global allergy immunotherapy market size is estimated to attain at 10% CAGR from 2024 to 2036. The market is expected to garner a revenue of USD 6...
Pulmonary Drug Delivery Devices Market revenue to hit USD 105 Billion by 2035, says Research Nester
31 janv. 2024 05h30 HE
|
Research Nester
New York, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The global pulmonary drug delivery devices market size is predicted to expand at ~7% CAGR between 2023 and 2035. The market is projected to garner a...